Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. News
  7. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
Delayed NSE India Stock Exchange  -  06:23:14 2023-02-03 am EST
1028.15 INR   +2.04%
02:44aIndia's Zydus Lifesciences beats Q3 profit view on strong India, U.S. sales
RE
02/02Nomura Adjusts Sun Pharmaceutical's Price Target to INR1,190 From INR1,094, Keeps at Buy
MT
02/01India's Alembic Pharma beats estimates on higher domestic sales
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sun Pharmaceutical's Psoriatic Arthritis Drug Up for Strong Sales Once Available

11/25/2022 | 05:29am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBVIE INC. 0.25% 145.2 Delayed Quote.-10.38%
SUN PHARMACEUTICAL INDUSTRIES LTD. 2.04% 1028.15 Delayed Quote.0.62%
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
02:44aIndia's Zydus Lifesciences beats Q3 profit view on strong India, U.S. sales
RE
02/02Nomura Adjusts Sun Pharmaceutical's Price Target to INR1,190 From INR1,094, Keeps at Bu..
MT
02/01India's Alembic Pharma beats estimates on higher domestic sales
RE
02/01Sun Pharmaceutical Industries' Consolidated Net Profit Rises in Fiscal Q3; EPS, Revenue..
MT
01/31Transcript : Sun Pharmaceutical Industries Limited, Q3 2023 Earnings Call, Ja..
CI
01/31India's Sun Pharma beats Q3 profit view on higher sales of specialty drugs
RE
01/31Sun Pharmaceutical Industries Limited Approves Interim Dividend for the Financial Year ..
CI
01/31Sun Pharmaceutical Industries Limited Announces Retirement of Kalyanasundaram Subramani..
CI
01/31Sun Pharmaceutical Industries Limited Reports Earnings Results for the Third Quarter an..
CI
01/30Sun Pharmaceutical Acquires Three Brands from Indian Healthcare Firm
MT
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Financials
Sales 2023 437 B 5 317 M 5 317 M
Net income 2023 84 697 M 1 030 M 1 030 M
Net cash 2023 133 B 1 616 M 1 616 M
P/E ratio 2023 29,2x
Yield 2023 0,78%
Capitalization 2 467 B 29 987 M 29 987 M
EV / Sales 2023 5,34x
EV / Sales 2024 4,73x
Nbr of Employees 38 000
Free-Float 44,4%
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 38
Last Close Price 1 028,15 INR
Average target price 1 154,95 INR
Spread / Average Target 12,3%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Davinder Singh Executive Vice President-Global Operations
Ashok I. Bhuta Compliance Officer & Senior GM-Secretarial
Anoop Deshpande Secretary & Compliance Officer